Corpus Intelligence IC Memo — ST. FRANCIS HOSPITAL INC 2026-04-26 03:50 UTC
IC Memo — ST. FRANCIS HOSPITAL INC
Investment Committee Memorandum | SC | 327 beds | Grade C | EBITDA uplift $50.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ST. FRANCIS HOSPITAL INC

CCN 420023 | GREENVILLE, SC | 327 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ST. FRANCIS HOSPITAL INC is a 327-bed suburban community hospital in GREENVILLE, SC with $691.4M in net patient revenue and a 4.9% operating margin. The hospital serves a payer mix of 25.4% Medicare, 2.8% Medicaid, and 71.8% commercial.

Thesis: Undervalued. Our ML models identify $50.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 4.9% to 12.3% (+736bps).

Net Revenue HCRIS$691.4M
Current EBITDA COMPUTED$33.9M
Operating Margin COMPUTED4.9%
Occupancy HCRIS75.1%
Revenue / Bed COMPUTED$2.1M
Net-to-Gross HCRIS17.6%
Distress Probability ML40.0%

2. Market Context & Competitive Position

85
SC Hospitals
1.3%
State Median Margin
19
Comparable Hospitals

SC has 85 Medicare-certified hospitals with a median operating margin of 1.3%. The target's margin of 4.9% places it above the state median. Among 19 size-comparable peers (164-654 beds), the median margin is -2.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (164-654), prioritizing same-state peers. 19 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ST. FRANCIS HOSPITAL INC (Target)SC327$691.4M4.9%
LEXINGTON MEDICAL CENTERSC541$1.43B1.1%
PRISMA HEALTH RICHLAND HOSPITASC600$913.3M0.4%
MCLEOD REGIONAL MEDICAL CENTERSC524$792.5M-4.9%
TRIDENT REGIONAL MEDICAL CENTESC388$637.5M16.1%
GRAND STRAND REGIONAL MEDICAL SC336$602.2M32.8%
ANMED HEALTHSC367$596.7M-2.3%
SELF REGIONAL HEALTHCARESC290$410.1M4.7%
ROPER HOSPITAL INC.SC266$400.8M-3.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $50.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$14.5M+210bp18mo
Cost to Collect4.5%2.5%$13.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$13.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$8.4M+122bp9mo
Clean Claim Rate88.0%96.0%$442K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$14.5M
Cost to Collect
$13.8M
Denial Rate Reduction
$13.7M
A/R Days Reduction
$8.4M
Clean Claim Rate
$442K
Total EBITDA Uplift$50.9M
Current EBITDA$33.9M
+ RCM Uplift+$50.9M
Pro Forma EBITDA$84.8M
Current Margin4.9%
Pro Forma Margin12.3%
WC Released (1x)$26.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$52.2M$732.8M14.03x69.6%
Base (11x exit)10.0x11.0x$52.2M$823.1M15.76x73.6%
Bull Case9.0x11.0x$47.0M$1.01B21.45x84.6%
Bull (12x exit)9.0x12.0x$47.0M$1.11B23.69x88.3%
Bear Case11.0x10.0x$57.4M$461.4M8.03x51.7%
Bear (11x exit)11.0x11.0x$57.4M$526.2M9.16x55.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 19 hospitals with 164-654 beds
  • Same-state prioritization (n=20)
  • Comp margins: P25=-11.0% / P50=-2.3% / P75=2.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.